Medical Xpress28d
FDA adds warning label to RSV vaccines Abrysvo and Arexvy about the risk for Guillain-Barré syndrome
Get Instant Summarized Text (Gist) The FDA has mandated safety labeling changes for the RSV vaccines Abrysvo and Arexvy to include warnings about the risk of Guillain-Barré syndrome (GBS ...
BioPharma Dive6d
GSK, Pfizer sales of RSV shots slow as vaccination rates ebb
Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their ...
Pharm Exec1mon
FDA Mandates Updates to Prescribing Information for RSV Vaccines Abrysvo, Arexvy for Increased Guillain-Barré Syndrome Risk
Potential cases of hospitalized GBS among recipients of Abrysvo and Arexvy were identified through International Classification of Diseases codes. 1 According to the Centers for Disease Control and ...
pharmaphorum1y
GSK to lean on Zhifei for Shingrix and maybe Arexvy in China
and may also call upon it to help it distribute new shot Arexvy. Herpes zoster vaccine Shingrix for shingles has been the main driver of GSK’s revenue growth for some time, accounting for £1.7 ...
Nasdaq1mon
FDA Urges Guillain-Barré Syndrome Warning On Labels Of RSV Vaccines Abrysvo And Arexvy
(RTTNews) - The FDA has required the manufacturers of the RSV Vaccines Abrysvo and Arexvy to add a new warning to their labels about the potential risk of Guillain-Barré Syndrome following ...